Stock Snapshot from
CASI Pharmaceuticals IncAdd to My Watchlist
CASI:USNASDAQ CMIndustry: Medical-Biomedical/Gene
- 1.80Last
- 0.04 -2.17%Today's Change
- 1.84Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.210 |
| EPS: Year Est. ttm | -- |
| EPS: Quarterly Actual | -0.06 |
| EPS: Quarterly Est. | -- |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | 71.79 |
Company Description
| CASI Pharmaceuticals Inc. researches and develops biopharmaceutical products that focus on the role of blood and blood vessels in health and disease. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. Therapeutics currently being researched include Endostatin and Angiostatin. | |
| Revenue | $0 |
| Net Income | $-6 million |
| Total Assets | $16 million |
| Employees | 15 |
| Web Site | www.casipharmaceuticals.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.